S20-039 Enhanced activation of CD8+ and CD4+ T cells by a vaccine targeting CD244 or CD48 Researchers at Stanford have developed a microparticle-based vaccine that in a single shot enables enhanced activation of CD8+ and/or CD4+ T cells to fight against infectious diseases and cancer. Thomas Cherpes Rodolfo Vicetti Miguel